Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thoracic Neoplasms × Ultrasonography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Liver Neoplasms 3 Thyroid Nodule 2 Polycystic Ovary Syndrome 2 Hypersensitivity 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Salivary Gland Diseases 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oligomenorrhea 1 Menstruation Disturbances 1 Malignant Tumor of Women's Reproductive System 1 Lung Neoplasms 1 Liver Cirrhosis 1 Leiomyoma 1 Intestinal Perforation 1 Hyperandrogenism 1 Hirsutism 1 Head and Neck Neoplasms 1 Enterocolitis, Necrotizing 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

apatinib 2 toripalimab 1 sintilimab 1 camrelizumab 1 Ultrasonography 1 TNFSF10 protein, human 1 Injections 1 Erlotinib Hydrochloride 1 Carboplatin 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡